LATEST MANUSCRIPTS IN Drug Target Insights
- Marcello Iriti. Natural Products & Phytotherapeutics: why a new section? Drug target insights. 2023, 17: 1-4
Cited : 0Read More - Gemini Gajera, Niel Henriksen, Bryan Cox, Vijay Kothari. Identification of anti-pathogenic activity among predicted small-molecule inhibitors of LasR or nitric oxide reductase (NOR). Drug target insights. 2023, 17: 101-109Cited : 0Read More
- Alessandro Inno, Giuseppe Bogina, Giulio Settanni, Matteo Salgarello, Giovanni Foti, Carlo Pomari, Vincenzo Picece, Stefania Gori. First-line tepotinib for a very elderly patient with metastatic NSCLC harboring exon 14 skipping mutation and high PD-L1 expression. Drug target insights. 2023, 17: 110-113Cited : 0Read More
- Ebtehaj Saud Almughais, Fatmah Fahad Alreshidi, Hussain Gadelkarim Ahmed. Prevalence of antibiotic misuse in cases of pneumonia and diarrhea in Saudi Arabia. Drug target insights. 2023, 17: 114-119Cited : 0Read More
- Apichart So-Ngern, Naphol Osaithai, Atibordee Meesing, Worawat Chumpangern. Mortality rate and factors associated with mortality of carbapenem-resistant Enterobacteriaceae infection. Drug target insights. 2023, 17: 120-125Cited : 0Read More
- Ria Pothoven. Management of urinary tract infections in the era of antimicrobial resistance. Drug target insights. 2023, 17: 126-137Cited : 1Read More
- Bhavya Shetty, Ibrahim Fazal, Safiya Fatima Khan, Manjusha Nambiar, Khadijathul Irfana D, Rohit Prasad, Akshata Raj. Association between cardiovascular diseases and periodontal disease: more than what meets the eye. Drug target insights. 2023, 17: 31-38Cited : 3Read More
- Vanessa Zambelli, Emma J Murphy, Paolo Delvecchio, Laura Rizzi, Roberto Fumagalli, Emanuele Rezoagli, Giacomo Bellani. Treatment with levosimendan in an experimental model of early ventilator-induced diaphragmatic dysfunction. Drug target insights. 2023, 17: 39-44Cited : 2Read More
- Supphachoke Khemla, Atibordee Meesing, Wantin Sribenjalux, Ploenchan Chetchotisakd. Lipid profiles of people with human immunodeficiency virus with dyslipidemia after switching from efavirenz to dolutegravir. Drug target insights. 2023, 17: 45-53Cited : 4Read More
- Ismin Zainol Abidin, Emma J Murphy, Gustavo Waltzer Fehrenbach, Emanuele Rezoagli, Noel Gately, Ian Major. A systematic review of mucoadhesive vaginal tablet testing. Drug target insights. 2023, 17: 5-30Cited : 3Read More
- Ratchanon Rattanathanoo, Jarin Chindaprasirt, Watchara Boonsawat, Panita Limpawattana, Sittichai Khamsai, Kittisak Sawanyawisuth. Are calcium channel blockers related to lung cancer? Drug target insights. 2023, 17: 54-57Cited : 0Read More
- Feny J Ruparel, Siddhi K Shah, Jhanvi H Patel, Nidhi R Thakkar, Gemini N Gajera, Vijay O Kothari. Network analysis for identifying potential anti-virulence targets from whole transcriptome of and exposed to certain anti-pathogenic polyherbal formulations. Drug target insights. 2023, 17: 58-69Cited : 0Read More
- Safiya Fatima Khan, Bhavya Shetty, Ibrahim Fazal, Asim Mustafa Khan, Faheem Muzaffar Mir, Muhamood Moothedath, V J Reshma, Muhaseena Muhamood. Licorice as a herbal extract in periodontal therapy. Drug target insights. 2023, 17: 70-77Cited : 0Read More
- Gurvinder Singh Bumbrah, Sarika Jain, Zeeshan Fatima, Saif Hameed. Efficacy of LAMP assay for Mycobacterial spp. detection to prevent treatment delays and onset of drug resistance: a systematic review and meta-analysis. Drug target insights. 2023, 17: 78-89Cited : 0Read More
- Alessandro Inno, Fabiana Marchetti, Matteo Valerio, Niccolò Giaj Levra, Filippo Alongi, Giovanni Foti, Stefania Gori. Activity of sotorasib against brain metastases from NSCLC harboring p.G12C mutation: a case report. Drug target insights. 2023, 17: 90-91Cited : 1Read More
